Coordinating smoking cessation treatment with menstrual cycle phase to improve quit outcomes (MC-NRT): study protocol for a randomized controlled trial

• Published in: Current controlled trials in cardiovascular medicine Vol. 24; no. 1; p. 251
• Main Authors: Zawertailo, Laurie, Kabir, Tina, Voci, Sabrina, Tanzini, Elise, Attwells, Sophia, Malat, Liliana, Veldhuizen, Scott, Minian, Nadia, Dragonetti, Rosa, Melamed, Osnat C, Mei-Dan, Elad, Selby, Peter
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 01.04.2023; BioMed Central; BMC
• Subjects: Abstinence; Addictions; Cancer; Clinical trials; Estrogen; Estrogens; Evaluation; Female; Health aspects; Hormones; Humans; Male; Menstrual Cycle; Menstruation; Mental health; Methods; Mortality; Nicotine; Ovarian hormones; Ovaries; Personal health; Progesterone; Randomized Controlled Trials as Topic; Smoking; Smoking - therapy; Smoking cessation; Smoking Cessation - methods; Smoking cessation programs; Smoking cessation treatment; Smoking Prevention - methods; Study Protocol; Success; Tobacco Use Cessation Devices - adverse effects; Womens health; Canada; Toronto Ontario Canada; Smoking cessation treatment; Smoking cessation; Menstrual cycle; Ovarian hormones; Estrogen; Nicotine replacement therapy; Cancer prevention; Progesterone; Nicotine dependence
• DOI: 10.1186/s13063-023-07196-1
• ISSN: 1745-6215

Women experience greater difficulty achieving smoking abstinence compared to men. Recent evidence suggests that hormonal fluctuations during different phases of the menstrual cycle can contribute to lower smoking abstinence rates following a quit attempt among women. However, these findings are limited by small sample sizes and variability among targeted smoking quit dates. This clinical trial aims to clarify whether targeting the quit date to the follicular or luteal phase of the menstrual cycle can improve smoking abstinence. Participants will enroll in an online smoking cessation program providing nicotine replacement therapy (NRT) and behavioral support. We will randomize 1200 eligible individuals to set a target quit date: (1) during the mid-luteal phase, (2) during the mid-follicular phase, or (3) 15-30 days after enrollment with no regard to the menstrual cycle phase (usual practice). Participants will receive a 6-week supply of combination NRT consisting of a nicotine patch plus their choice of nicotine gum or lozenge. Participants will be instructed to start using NRT on their target quit date. Optional behavioral support will consist of a free downloadable app and brief videos focusing on building a quit plan, coping with cravings, and relapse prevention, delivered via e-mail. Smoking status will be assessed via dried blood spot analysis of cotinine concentration at 7 days, 6 weeks, and 6 months post-target quit date. We aim to overcome the limitations of previous studies by recruiting a large sample of participants and assigning target quit dates to the middle of both the follicular and luteal phases. The results of the trial can further elucidate the effects of the menstrual cycle on smoking cessation outcomes and whether it is beneficial to combine menstrual cycle phase timing strategies with accessible and low-cost NRT. ClinicalTrials.gov NCT05515354. Registered on August 23, 2022.